Simultaneous determination of four basic metabolites formed from butyrophenone type agents by HPLC with dual ultraviolet detection

Journal of Liquid Chromatography and Related Technologies

Volumn 29, Issue 19, 2006, Pages 2853-2862

  Higashi, Yasuhiko ^a   Sakata, Masatoshi ^a   Fujii, Youichi ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Basic metabolite; Butyrophenone type agent; Dual ultraviolet detection; High performance liquid chromatography

Indexed keywords

ACETONITRILE; ASSAYS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ORGANIC COMPOUNDS; PHOSPHATES; ULTRAVIOLET RADIATION;

BASIC METABOLITES; BUTYROPHENONE-TYPE AGENTS; DUAL ULTRAVIOLET DETECTION;

METABOLITES;

1 PHENYL 1,3,8 TRIAZASPIROL[4.5]DECAN 4 ONE; 1,3 DIHYDRO 1 (1,2,3,6 TETRAHYDRO 4 PYRIDINYL) 2H BENZIMIDAZOLE 2 NE; 4 (4 BROMOPHENYL) 4 HYDROXYPIPERIDINE; 4 (4 CHLOROPHENYL) 4 HYDROXYPIPERADINE; ACETONITRILE; BROMPERIDOL; BUTYROPHENONE DERIVATIVE; DROPERIDOL; DRUG METABOLITE; HALOPERIDOL; PHOSPHATE BUFFERED SALINE; PHOSPHORIC ACID; PIPERIDINE DERIVATIVE; SPIPERONE; UNCLASSIFIED DRUG; WATER;

ACCURACY; ARTICLE; DEALKYLATION; DRUG STRUCTURE; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; ULTRAVIOLET SPECTROSCOPY;

EID: 33750486801     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070600959476     Document Type: Article

References (14)

1. Fang, J.; McKay, G.; Song, J.; Remillrd, A.; Li, X.; Midha, K. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Drug Metab. Dispos. 2001, 29, 1638-1643.
2. Kalgutkar, A.S.; Taylor, T.J.; Venkatakrishnan, K.; Isin, E.M. Assessment of the contributions of CYP3A4 and CYP3A5 in the metabolism of the antipsychotic agent haloperidol to its potentially neurotoxic pyridinium metabolite and effect of antidepressants on the bioactivation pathway. Drug Metab. Dispos. 2003, 31, 243-249.
3. Ablordeppey, S.Y.; Borne, R.F.; Davis, W.M. Freezing action of a metabolite of haloperidol in frogs. Biochem. Pharmacol. 1992, 43, 2181-2187.
4. Bowen, W.D.; Moses, E.L.; Tolentino, P.J.; Walker, J.M. Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors. Eur. J. Pharmacol. 1990, 177, 111-118.
5. Fukuoka, T.; Nakano, M.; Kohda, A.; Okuno, Y.; Matsuo, M. The common marmoset (Callithrix jacchus) as a model for neuroleptic-induced acute dystonia. Pharmacol. Biochem. Behav. 1997, 58, 947-953.
6. Yasui-Furukori, N.; Kondo, T.; Ishida, M.; Tanaka, O.; Mihara, K.; Kaneko, S.; Otani, K. The characteristics of side-effects of bromperidol in schizophrenic patients. Psychiatry Clin. Neurosci. 2002, 56, 103-106.
7. Fornai, F.; Schluter, O.M.; Lenzi, P.; Gesi, M.; Ruffoli, R.; Ferrucci, M.; Lazzeri, G.; Busceti, C.L.; Pontarelli, F.; Battaglia, G.; Pellegrini, A.; Nicoletti, F.; Ruggieri, S.; Paparelli, A.; Sudhof, T.C. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc. Natl. Acad. Sci. USA. 2005, 102, 3413-3418.
8. Fang, J.; Baker, G.B.; Coutts, R.T. Determination of 4-(4-chlorophenyl)- 4-hydroxypiperidine, a metabolite of haloperidol, by gas chromatography with electron-capture detection. J. Chromatogr. B 1996, 682, 283-288.
9. Arinobu, T.; Hattori, H.; Iwai, M.; Ishii, A.; Kumazawa, T.; Suzuki, O.; Seno, H. Liquid chromatographic-mass spectrometric determination of haloperidol and its metabolites in human plasma and urine. J. Chromatogr. B 2002, 776, 107-113.
10. Arinobu, T.; Hattori, H.; Seno, H.; Ishii, A.; Suzuki, O. Comparison of SSI with APCI as an interface of HPLC-mass spectrometry for analysis of a drug and its metabolites. J. Am. Soc. Mass Spectrom. 2002, 13, 204-208.
11. Gorrod, J.W.; Fang, J. On the metabolism of haloperidol. Xenobiotica 1993, 23, 495-508.
12. Higashi, Y.; Nakamura, S.; Fujii, Y. Sensitive determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, in a rat biological sample by HPLC with fluorescence detection after pre-column derivatization using 4-fluoro-7-nitro-2,1,3-benzoxadiazole. Biomed. Chromatogr. 2006, accepted.
13. Fang, J.; Gorrod, J.W. High performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations. J. Chromatogr. 1993, 614, 267-273.
14. Higashi, Y.; Kitahara, M.; Fujii, Y. Simultaneous analysis of haloperidol, its three metabolites and two other butyrophenone-type neuroleptics by high performance liquid chromatography with dual ultraviolet detection. Biomed. Chromatogr. 2006, 20, 166-172.